DexCom Stock Hits New 52-Week Low (DXCM)

NEW YORK ( TheStreet) -- DexCom (Nasdaq: DXCM) hit a new 52-week low Thursday as it is currently trading at $9.82, below its previous 52-week low of $9.83 with 702,930 shares traded as of 1:46 p.m. ET. Average volume has been 566,800 shares over the past 30 days.

DexCom has a market cap of $705.6 million and is part of the health care sector and health services industry. Shares are down 25.4% year to date as of the close of trading on Wednesday.

DexCom, Inc., a medical device company, engages in the design, development, and commercialization of continuous glucose monitoring systems for people with diabetes in the United States.
  • Practice your DXCM trading strategies and win cash in our stock game.

TheStreet Ratings rates DexCom as a sell. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. You can view the full DexCom Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

null

More from Markets

Watch: Here's What Wall Street Is Tracking Monday as Trump Sends Stocks Lower

Watch: Here's What Wall Street Is Tracking Monday as Trump Sends Stocks Lower

Dow Falls Sharply, Nasdaq Sinks as Wall Street Weighs Trump's New Trade Threats

Dow Falls Sharply, Nasdaq Sinks as Wall Street Weighs Trump's New Trade Threats

This Will Be the Ultimate Buy (or Sell) Signal for Stocks

This Will Be the Ultimate Buy (or Sell) Signal for Stocks

Boeing Slides as China Premier Li Says Willing to Continue Talks With Airbus

Boeing Slides as China Premier Li Says Willing to Continue Talks With Airbus

Jim Cramer: Reports of Attempted Trade Truce With China Are False

Jim Cramer: Reports of Attempted Trade Truce With China Are False